Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

29d ago

EBS

PremiumPress Releases

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

1M ago

EBS

PremiumPress Releases

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

2M ago

EBS

PremiumCompany Announcements

Emergent BioSolutions Secures Flexible Credit Terms and Guarantor

2M ago

EBS

PremiumPress Releases

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

2M ago

EBS

PremiumCompany Announcements

Emergent Biosolutions Welcomes Joseph Papa as New CEO

2M ago

EBS

More EBS News >

ER4 News on the Web

2024-04-22

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024

Yahoo Finance

Neutral

2024-04-17

Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s recent 16% drop adds to one-year losses

Yahoo Finance

Neutral

2024-04-01

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

Yahoo Finance

Neutral

2024-03-28

Analyst Rating: Will Emergent Biosolutions Inc (EBS) Stock Do Better Than the Market?

Investors Observer

Neutral

2024-03-28

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

Yahoo Finance

Neutral

2024-03-25

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

Yahoo Finance

Bullish

2024-03-14

How Does Emergent Biosolutions Inc (EBS) Stock Rank on Wall Street Thursday?

Investors Observer

Neutral

2024-03-11

Emergent Biosolutions Inc (EBS) is down -11.04% in a Week, Should You Buy?

Investors Observer

Neutral

News Score - Last 7 Days

Neutral

DE:ER4

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ER4’s Media Buzz Sentiment?

1 articles about DE:ER4 were published this week. In an average week, 1 articles are published.

What is DE:ER4’s weekly average amount of articles?

In an average week, 1 articles about DE:ER4 are published.

What is DE:ER4’s News Sentiment?

50% of articles about DE:ER4 were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

TAKTakeda Pharmaceutical Company

NBIXNeurocrine

AMEDAmedisys

MORFMorphic Holding

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing